Currently we test and support the following browsers:
Solid Tumor : Previously treated or untreated, unresectable Stage III or Stage IV malignant melanoma
This is a non-randomized, multicenter, open label Phase 2 study in adolescent subjects (12 to <18 years of age) with previously treated or untreated unresectable Stage III or Stage IV malignant melanoma. This study will enroll approximately 30 patients.
For the current eligibility status of this clinical study, referring physicians must contact St. Jude Children's Research Hospital at 1-866-2ST-JUDE (1-866-278-5833).
Alberto Pappo, MD
St. Jude Children’s Research Hospital
262 Danny Thomas Place
Memphis, TN 38105 USA
Voice: 1-888-226-4343 or 901-595-4055
Referring or consulting physicians only: firstname.lastname@example.org
For all other inquiries about St. Jude Children's Research Hospital studies: email@example.com
The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.